Compare CAG & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAG | LNTH |
|---|---|---|
| Founded | 1919 | 1956 |
| Country | United States | United States |
| Employees | 26100 | N/A |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 6.5B |
| IPO Year | 1994 | 2014 |
| Metric | CAG | LNTH |
|---|---|---|
| Price | $14.73 | $101.63 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 9 |
| Target Price | $13.74 | ★ $105.99 |
| AVG Volume (30 Days) | ★ 10.0M | 1.0M |
| Earning Date | 12-18-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.36 | ★ 3.21 |
| Revenue | ★ $1,500,000,000.00 | $343,374,000.00 |
| Revenue This Year | N/A | $0.40 |
| Revenue Next Year | N/A | $8.23 |
| P/E Ratio | $40.42 | ★ $31.52 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $12.53 | $51.80 |
| 52 Week High | $20.32 | $111.86 |
| Indicator | CAG | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 63.61 |
| Support Level | $14.44 | $99.84 |
| Resistance Level | $15.44 | $102.66 |
| Average True Range (ATR) | 0.41 | 0.48 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 52.87 | 92.08 |
Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.